- Home
- CLMT
CLMT
Calumet Specialty Products Partners L.P. Common Units
as 05-09-2025 4:00pm EST
| Founded: | 1916 | Country: | United States |
| Employees: | N/A | City: | INDIANAPOLIS |
| Market Cap: | N/A | IPO Year: | 2006 |
| Target Price: | $21.60 | AVG Volume (30 days): | 951.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.67 | EPS Growth: | N/A |
| 52 Week Low/High: | $7.68 - $25.29 | Next Earning Date: | 05-09-2025 |
| Revenue: | $4,189,399,999 | Revenue Growth: | 0.20% |
| Revenue Growth (this year): | -8.87% | Revenue Growth (next year): | 1.44% |
Latest Calumet Specialty Products Partners L.P. Common Units News
CLMT Breaking Stock News: Dive into CLMT Ticker-Specific Updates for Smart Investing
PR Newswire
11 hours ago
Calumet Reports First Quarter 2025 Results
GuruFocus.com
a day ago
Calumet Inc (CLMT) Q1 2025: Everything You Need to Know Ahead of Earnings
PR Newswire
14 days ago
Calumet, Inc. to Release First Quarter 2025 Earnings on May 9, 2025
Insider Monkey
25 days ago
Calumet, Inc. (CLMT): A Bull Case Theory
PR Newswire
a month ago
Calumet Announces Closing of Sale of Assets Related to Industrial Portion of its Royal Purple® Business
PR Newswire
2 months ago
Calumet Announces Intention to Nominate Julio Quintana and Karen Narwold to Board of Directors; and Wasserstein Debt Opportunities Expresses Support
PR Newswire
2 months ago
Calumet to Attend Wolfe Research Conference
Insider Monkey
2 months ago
Here are Crossroads Capital’s Updates on Calumet (CLMT)
Compare CLMT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CLMT Calumet Specialty Products Partners L.P. Common Units - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.